CIK 0000939767
EXEL EXELIXIS, INC.
Insider trading from SEC Form 4. Last filing Dec 23, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at EXELIXIS, INC., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 38Weak | sell 2 | Hessekiel Jeffrey EVP & General Counsel | $2.2M | 60,000 | -11% | - | |
| 18Weak | sell 210b5-1 | Haley Patrick J. EVP, Commercial | $353k | 10,000 | -3% | - | |
| 40Moderate | sell 310b5-1 | Haley Patrick J. EVP, Commercial | $1.4M | 41,588 | -13% | - | |
| 25Weak | sell 410b5-1 | Aftab Dana CSO/EVP Disc & Trans Research | $3.4M | 96,986 | -16% | - | |
| 60Notable | sell 3 | POSTE GEORGE director | $1.0M | 30,000 | -15% | - | |
| 35Weak | sell 310b5-1 | Hessekiel Jeffrey EVP & General Counsel | $1.7M | 50,000 | -9% | - | |
| 16Weak | sell 310b5-1 | Aftab Dana CSO/EVP Disc & Trans Research | $36k | 1,162 | -0% | - | |
| 31Weak | sell 310b5-1 | Hessekiel Jeffrey EVP & General Counsel | $710k | 25,000 | -4% | - |
Transactions
The last 24 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | MORRISSEY MICHAEL President and CEO | GGift Common Stock | -179,788 | $0.00 | $0 | 736,954 | Dec 23, 2024 |
| Dec 20, 2024 | MORRISSEY MICHAEL President and CEO | GGift Common Stockindirect: By Trust | +179,788 | $0.00 | $0 | 1,587,000 | Dec 23, 2024 |
| Nov 27, 2024 | Hessekiel Jeffrey EVP & General Counsel | MOption exercise Common Stock | +129,314 | $18.80 | $2.4M | 644,967 | Dec 2, 2024 |
| Nov 27, 2024 | Hessekiel Jeffrey EVP & General Counsel | FTax withholding Common Stock | -98,908 | $35.93 | $3.6M | 546,059 | Dec 2, 2024 |
| Nov 29, 2024 | Hessekiel Jeffrey EVP & General Counsel | SOpen-market sale Common Stock | -60,000 | $36.67 | $2.2M | 486,059 | Dec 2, 2024 |
| Nov 29, 2024 | Hessekiel Jeffrey EVP & General Counsel | GGift Common Stock | -15,000 | $0.00 | $0 | 471,059 | Dec 2, 2024 |
| Nov 27, 2024 | Hessekiel Jeffrey EVP & General Counsel | MOption exercise Option (right to buy)derivative | -129,314 | $0.00 | $0 | 0 | Dec 2, 2024 |
| Nov 22, 2024 | Haley Patrick J. EVP, Commercial | SOpen-market sale Common Stock10b5-1 | -10,000 | $35.27 | $353k | 278,665 | Nov 26, 2024 |
| Nov 15, 2024 | Hessekiel Jeffrey EVP & General Counsel | FTax withholding Common Stock | -14,672 | $35.05 | $514k | 515,653 | Nov 19, 2024 |
| Nov 15, 2024 | Senner Christopher J. EVP and CFO | FTax withholding Common Stock | -17,506 | $35.05 | $614k | 704,174 | Nov 19, 2024 |
| Nov 15, 2024 | MORRISSEY MICHAEL President and CEO | FTax withholding Common Stock | -47,642 | $35.05 | $1.7M | 916,742 | Nov 19, 2024 |
| Nov 15, 2024 | Haley Patrick J. EVP, Commercial | FTax withholding Common Stock10b5-1 | -14,672 | $35.05 | $514k | 330,253 | Nov 19, 2024 |
| Nov 15, 2024 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | FTax withholding Common Stock | -27,224 | $35.05 | $954k | 294,897 | Nov 19, 2024 |
| Nov 15, 2024 | Aftab Dana CSO/EVP Disc & Trans Research | FTax withholding Common Stock | -12,838 | $35.05 | $450k | 486,107 | Nov 19, 2024 |
| Nov 18, 2024 | Haley Patrick J. EVP, Commercial | SOpen-market sale Common Stock10b5-1 | -22,207 | $34.31 | $762k | 308,046 | Nov 19, 2024 |
| Nov 18, 2024 | Haley Patrick J. EVP, Commercial | SOpen-market sale Common Stock10b5-1 | -19,381 | $34.41 | $667k | 288,665 | Nov 19, 2024 |
| Nov 5, 2024 | Aftab Dana CSO/EVP Disc & Trans Research | MOption exercise Common Stock10b5-1 | +96,986 | $18.80 | $1.8M | 595,931 | Nov 7, 2024 |
| Nov 5, 2024 | Aftab Dana CSO/EVP Disc & Trans Research | SOpen-market sale Common Stock10b5-1 | -96,986 | $35.00 | $3.4M | 498,945 | Nov 7, 2024 |
| Nov 5, 2024 | Aftab Dana CSO/EVP Disc & Trans Research | MOption exercise Option (right to buy)derivative10b5-1 | -96,986 | $0.00 | $0 | 0 | Nov 7, 2024 |
| Nov 1, 2024 | POSTE GEORGE director | SOpen-market sale Common Stock | -30,000 | $34.00 | $1.0M | 169,020 | Nov 5, 2024 |
| Nov 1, 2024 | Hessekiel Jeffrey EVP & General Counsel | SOpen-market sale Common Stock10b5-1 | -50,000 | $34.13 | $1.7M | 530,325 | Nov 5, 2024 |
| Oct 31, 2024 | MORRISSEY MICHAEL President and CEO | GGift Common Stockindirect: By Trust | -46,000 | $0.00 | $0 | 1,407,212 | Nov 1, 2024 |
| Oct 30, 2024 | Aftab Dana CSO/EVP Disc & Trans Research | SOpen-market sale Common Stock10b5-1 | -1,162 | $31.40 | $36k | 498,945 | Nov 1, 2024 |
| Oct 28, 2024 | Hessekiel Jeffrey EVP & General Counsel | SOpen-market sale Common Stock10b5-1 | -25,000 | $28.39 | $710k | 580,325 | Oct 30, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Aftab DanaCSO/EVP Disc & Trans Research
- Haley Patrick J.EVP, Commercial
- Hessekiel JeffreyEVP & General Counsel
- MORRISSEY MICHAELPresident and CEO
- POSTE GEORGEdirector
- Peterson Amy C.EVP Prod Dev & Med Aff & CMO
- Senner Christopher J.EVP and CFO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.